Corporate Development

The current focus of the company is to refine a technology for the isolation and use of autologous stem cells for regenerative medicine applications with an initial focus on neural regeneration in patients of spinal cord injury (SCI). Celvive, Inc. has developed a new approach, using a closed bag system to isolate specific Adult Stem Cells from the patients' self Bone Marrow to treat SCI.